Global Cell Therapy Manufacturing market stood at USD3123.44 million in 2020 and is expected to grow at a steady CAGR of 12.0% during the forecast period. The market growth can be attributed to advancing biopharmaceutical industries, all over the globe. The development of the advancing therapies and transforming paradigm of several life-threatening diseases is driving the growth of the global cell therapy manufacturing market in the upcoming five years. Apart of that growing prevalence of diseases such as cancer, cardiovascular diseases, diabetes, and others is expected to support the growth of the market.

Healthcare industry is involved in the extensive research and technological advancements that leads to the advanced medicine and treatment facilities for the patients. The urgent need for effective therapies as well as a vaccine against the infection supported the exponential growth in the market in the past two years. The market is expected to sustain similar growth in future five years on the same factor. Although the research is consistently growing, the expertise in the sector is limited and the lack of specialized infrastructure to produce cell therapies and various product development may cause a mild restraint on the future growth of the market.

Sudden Outbreak & Spread of COVID-19 Driving Market Growth

Sudden outbreak & spread of COVID-19 drives the growth of cell therapy manufacturing market. Due to COVID-19, a rapid increase in research and development of cell-based vaccines for the treatment of COVID-19 was observed. However, Novartis continued to supply raw materials for cell-based therapies. Many of the raw materials used to manufacture viral vector-based vaccines have been transferred to develop and manufacture what could be billions of doses of COVID-19 vaccines. several biotech organizations took the initiative to examine the virus’s genome to come up with a sustainable vaccine. For instance, in November 2020, Novartis obtained the license for the Mesoblast’s cell therapy Remestemcel-L for the treatment of COVID-19.

Growing Popularity of Regenerative Medicine

Regenerative medicine is still in its infancy, but patient demand and ease of use are growing among healthcare experts. Significant development and advancement in regenerative medicine for the treatment of chronic ailment is driving the growth of cell-based therapies in the market. For example, RepliCel Life Sciences has announced commercialization and clinical testing in projects related to regenerative medicine, including cell-based therapies for skin rejuvenation and tendon regeneration.

Rising Prevalence of Cancer, Cardiac and Other Ailments

There has been a tremendous rise in cardiac cases, cancer ailments, and other diseases since the past decade, resulting in the rising need for cell-based therapies. Many innovative approaches are being developed to repair damaged heart muscle using cell-based therapies. Human retinal pigment epithelium and photoreceptor cells are employed in retinal cell therapy programs for dry age-related macular degeneration (AMD) and inherited retinal diseases (IRDs), which are now in pre-clinical research. Hence, the rising prevalence of diseases contributes to the growth of the cell-based therapies market.

Rising Government Investments in Cell-Based Research

The presence of government and commercial funding agencies that are continually issuing grants to support projects at various phases of clinical trials can be ascribed to the growing number of ongoing clinical studies and the introduction of innovative solutions, boosting the cell therapy manufacturing market. The growing awareness pertaining to health and hygiene has led to an increase in expenditure by different governments across the globe to develop adequate healthcare infrastructure in their countries, leading to the growth and development of new innovative cell-based therapies by various companies and universities.


Click here to download the sample

Market Segmentation

The global Cell Therapy Manufacturing market is segmented based on therapy, source of cell, scale of operation, source, application, end user, company, and regional distribution. Based on therapy, the market is segmented into T-cell therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies. Based on Source of Cell, the market is divided into Autologous and Allogenic. In terms of Scale of Operation, the market can be categorized into Preclinical, Clinical and Commercial. By Source, the market can be fragmented into In-House Manufacturing and Contract Manufacturing. Based on application, the market can be segmented into Oncology, Cardiovascular Diseases, Orthopedic Diseases and Others. Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Others.

North America dominates the market of Cell Therapy Manufacturing. United States Cell Therapy Manufacturing Market expected to grow at a CAGR of 12.75% during the Forecast Period.

Company Profiles

Novartis AG, F. Hoffmann-La Roche AG, Gilead Sciences, Inc., Thermo Fischer Scientific, Inc., Catalent, Inc., JSR Life Sciences LLC (KBI Biopharma Inc), Waisman Center (Waisman Biomanufacturing), Cell and Gene Therapy Catapult, Merck KGaA, Lonza Group, Oxford Biomedica Plc, WuXi AppTec, Charles River Laboratoires International Inc., Institut Merieux (ABL Inc.), BioCentriq, Centre for Commercialization of Regenerative Medicine (CCRM), Fujifilm Holdings Corporation (Fujifilm Cellular Dynamics), Amgen Inc., Bluebird Bio Inc., Takeda Pharmaceutical Company Limited are among the major market players in the global platform that lead the market growth of the global Cell Therapy Manufacturing market.

Attribute

Details

Market Size Value in 2020

USD 3123.44 Million

Revenue Forecast in 2026

USD 6015.09 Million

United States Market Size value in 2020

USD 870.94 Million

Growth Rate

12.0%

Base Year

2020

Historical Years

2016 – 2019

Estimated Year

2021

Forecast Period

2022 – 2026

Quantitative Units

Revenue in USD Million, and CAGR for 2016-2020 and 2021-2026

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

  • Flavor Type
  • Source of Cell
  • Scale of Operation
  • Source
  • Application
  • End User

Regional Scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country Scope

United States; Mexico; Canada; Germany; France; United Kingdom; Spain; Italy; China; Japan; South Korea; Australia; India; Brazil; Argentina; Colombia; Israel; South Africa; Saudi Arabia; UAE

Key Companies Profiled

Novartis AG, F. Hoffmann-La Roche AG, Gilead Sciences, Inc., Thermo Fischer Scientific, Inc., Catalent, Inc., JSR Life Sciences LLC (KBI Biopharma Inc), Waisman Center (Waisman Biomanufacturing), Cell and Gene Therapy Catapult, Merck KGaA, Lonza Group, Oxford Biomedica Plc, WuXi AppTec, Charles River Laboratories International Inc., Institut Merieux (ABL Inc.), BioCentriq, Centre for Commercialization of Regenerative Medicine (CCRM), Fujifilm Holdings Corporation (Fujifilm Cellular Dynamics), Amgen Inc., Bluebird Bio Inc., Takeda Pharmaceutical Company Limited

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request)

 

Report Scope:

In this report, global Cell Therapy Manufacturing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Cell Therapy Manufacturing Market, By Therapy:
    • T-Cell Therapies
    • Dendritic Cell Therapies
    • Tumor Cell Therapies
    • Stem Cell Therapies
  • Global Cell Therapy Manufacturing Market, By Source of Cell:
    • Autologous
    • Allogenic
  • Global Cell Therapy Manufacturing Market, By Scale of Operation:
    • Preclinical
    • Clinical
    • Commercial
  • Global Cell Therapy Manufacturing Market, By Source:
    • In-House
    • Contract Manufacturing
  • Global Cell Therapy Manufacturing Market, By Application:
    • Oncology
    • Cardiovascular Diseases
    • Orthopedic Diseases
    • Others
  • Global Cell Therapy Manufacturing Market, By End User:
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • Others
  • Global Cell Therapy Manufacturing Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • Asia-Pacific
      • China
      • Japan
      • South Korea
      • Australia
      • India
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • Israel
      • South Africa
      • Saudi Arabia
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Cell Therapy Manufacturing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.     Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Cell Therapy Manufacturing Market

5.    Voice of Customers

5.1.  Brand Awareness

5.2.  Commonly Used Cell Therapies

5.3.  Preferences Based on Source of Cell Among Medical Professionals

6.    Global Cell Therapy Manufacturing Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies)

6.2.2.     By Source of Cell (Autologous v/s Allogenic)

6.2.3.     By Scale of Operation (Preclinical, Clinical, Commercial)

6.2.4.     By Source (In-House v/s Contract Manufacturing)

6.2.5.     By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others)

6.2.6.     By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)

6.2.7.     By Company (2020)

6.2.8.     By Region

6.3.  Product Market Map

6.3.1.     By Therapy

6.3.2.     By Scale of Operation

6.3.3.     By Source

6.3.4.     By Application

6.3.5.     By Region

7.    North America Cell Therapy Manufacturing Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Therapy

7.2.2.     By Source of Cell

7.2.3.     By Scale of Operation

7.2.4.     By Source

7.2.5.     By Application

7.2.6.     By End User

7.2.7.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Cell Therapy Manufacturing Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Therapy

7.3.1.2.2.             By Source of Cell

7.3.1.2.3.             By Scale of Operation

7.3.1.2.4.             By Source

7.3.1.2.5.             By Application

7.3.1.2.6.             By End User

7.3.2.     Canada Cell Therapy Manufacturing Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Therapy

7.3.2.2.2.             By Source of Cell

7.3.2.2.3.             By Scale of Operation

7.3.2.2.4.             By Source

7.3.2.2.5.             By Application

7.3.2.2.6.             By End User

7.3.3.     Mexico Cell Therapy Manufacturing Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Therapy

7.3.3.2.2.             By Source of Cell

7.3.3.2.3.             By Scale of Operation

7.3.3.2.4.             By Source

7.3.3.2.5.             By Application

7.3.3.2.6.             By End User

8.    Europe Cell Therapy Manufacturing Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Therapy

8.2.2.     By Source of Cell

8.2.3.     By Scale of Operation

8.2.4.     By Source

8.2.5.     By Application

8.2.6.     By End User

8.2.7.     By Country

8.3.  Europe: Country Analysis

8.3.1.     Germany Cell Therapy Manufacturing Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Therapy

8.3.1.2.2.             By Source of Cell

8.3.1.2.3.             By Scale of Operation

8.3.1.2.4.             By Source

8.3.1.2.5.             By Application

8.3.1.2.6.             By End User

8.3.2.     France Cell Therapy Manufacturing Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Therapy

8.3.2.2.2.             By Source of Cell

8.3.2.2.3.             By Scale of Operation

8.3.2.2.4.             By Source

8.3.2.2.5.             By Application

8.3.2.2.6.             By End User

8.3.3.     United Kingdom Cell Therapy Manufacturing Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Therapy

8.3.3.2.2.             By Source of Cell

8.3.3.2.3.             By Scale of Operation

8.3.3.2.4.             By Source

8.3.3.2.5.             By Application

8.3.3.2.6.             By End User

8.3.4.     Spain Cell Therapy Manufacturing Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Therapy

8.3.4.2.2.             By Source of Cell

8.3.4.2.3.             By Scale of Operation

8.3.4.2.4.             By Source

8.3.4.2.5.             By Application

8.3.4.2.6.             By End User

8.3.5.     Italy Cell Therapy Manufacturing Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Therapy

8.3.5.2.2.             By Source of Cell

8.3.5.2.3.             By Scale of Operation

8.3.5.2.4.             By Source

8.3.5.2.5.             By Application

8.3.5.2.6.             By End User

9.    Asia-Pacific Cell Therapy Manufacturing Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Therapy

9.2.2.     By Source of Cell

9.2.3.     By Scale of Operation

9.2.4.     By Source

9.2.5.     By Application

9.2.6.     By End User

9.2.7.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Cell Therapy Manufacturing Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Therapy

9.3.1.2.2.             By Source of Cell

9.3.1.2.3.             By Scale of Operation

9.3.1.2.4.             By Source

9.3.1.2.5.             By Application

9.3.1.2.6.             By End User

9.3.2.     Japan Cell Therapy Manufacturing Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Therapy

9.3.2.2.2.             By Source of Cell

9.3.2.2.3.             By Scale of Operation

9.3.2.2.4.             By Source

9.3.2.2.5.             By Application

9.3.2.2.6.             By End User

9.3.3.     South Korea Cell Therapy Manufacturing Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Therapy

9.3.3.2.2.             By Source of Cell

9.3.3.2.3.             By Scale of Operation

9.3.3.2.4.             By Source

9.3.3.2.5.             By Application

9.3.3.2.6.             By End User

9.3.4.     Australia Cell Therapy Manufacturing Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Therapy

9.3.4.2.2.             By Source of Cell

9.3.4.2.3.             By Scale of Operation

9.3.4.2.4.             By Source

9.3.4.2.5.             By Application

9.3.4.2.6.             By End User

9.3.5.     India Cell Therapy Manufacturing Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Therapy

9.3.5.2.2.             By Source of Cell

9.3.5.2.3.             By Scale of Operation

9.3.5.2.4.             By Source

9.3.5.2.5.             By Application

9.3.5.2.6.             By End User

10.  South America Cell Therapy Manufacturing Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Therapy

10.2.2.  By Source of Cell

10.2.3.  By Scale of Operation

10.2.4.  By Source

10.2.5.  By Application

10.2.6.  By End User

10.2.7.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Cell Therapy Manufacturing Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Therapy

10.3.1.2.2.           By Source of Cell

10.3.1.2.3.           By Scale of Operation

10.3.1.2.4.           By Source

10.3.1.2.5.           By Application

10.3.1.2.6.           By End User

10.3.2.  Argentina Cell Therapy Manufacturing Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Therapy

10.3.2.2.2.           By Source of Cell

10.3.2.2.3.           By Scale of Operation

10.3.2.2.4.           By Source

10.3.2.2.5.           By Application

10.3.2.2.6.           By End User

10.3.3.  Colombia Cell Therapy Manufacturing Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Therapy

10.3.3.2.2.           By Source of Cell

10.3.3.2.3.           By Scale of Operation

10.3.3.2.4.           By Source

10.3.3.2.5.           By Application

10.3.3.2.6.           By End User

11.  Middle East and Africa Cell Therapy Manufacturing Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Therapy

11.2.2.  By Source of Cell

11.2.3.  By Scale of Operation

11.2.4.  By Source

11.2.5.  By Application

11.2.6.  By End User

11.2.7.  By Country

11.3.              MEA: Country Analysis

11.3.1.  Israel Cell Therapy Manufacturing Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Therapy

11.3.1.2.2.           By Source of Cell

11.3.1.2.3.           By Scale of Operation

11.3.1.2.4.           By Source

11.3.1.2.5.           By Application

11.3.1.2.6.           By End User

11.3.2.  South Africa Cell Therapy Manufacturing Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Therapy

11.3.2.2.2.           By Source of Cell

11.3.2.2.3.           By Scale of Operation

11.3.2.2.4.           By Source

11.3.2.2.5.           By Application

11.3.2.2.6.           By End User

11.3.3.  Saudi Arabia Cell Therapy Manufacturing Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Therapy

11.3.3.2.2.           By Source of Cell

11.3.3.2.3.           By Scale of Operation